Editorial: HO-1, a new target of PPARσ with 'anti-atherogenic' properties: Is it the one?

Cardiovascular Research

Volumn 85, Issue 4, 2010, Pages 647-648

  Thorin Trescases, Nathalie ^a   Thorin, Eric ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; FIBRIC ACID DERIVATIVE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROBUCOL; PROTEIN P21; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL PROTECTION; DIABETES MELLITUS; DRUG MECHANISM; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; RISK FACTOR; SIGNAL TRANSDUCTION; UMBILICAL CORD; VASCULAR RESISTANCE; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM CELL; NOTE; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; HEME OXYGENASE-1; HUMANS; OXIDATIVE STRESS; PPAR DELTA;

EID: 76749163692     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp424     Document Type: Editorial

References (16)

1. Robinson E, Grieve DJ. Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease. Pharmacol Ther 2009;122:246-263.
2. Campia U, Matuskey LA, Panza JA. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in non-diabetic patients with major cardiovascular risk factors. Circulation 2006;113:867-875.
3. Duan SZ, Usher MG, Mortensen RM. PPARs: the vasculature, inflammation and hypertension. Curr Opin Nephrol Hypertens 2009;18:128-133.
4. Lim HJ, Lee S, Park JH, Lee KS, Choi HE, Chung KS et al. PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle. Atherosclerosis 2009;202:446-454.
5. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ et al. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 2007;27:1276-1282.
6. Stocker R, Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 2006;114:2178-2189.
7. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998;152:711-720.
8. Ali F, Ali NS, Bauer A, Boyle JJ, Hamdulay SS, Haskard DO et al. PPARd and PGC1a act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. Cardiovasc Res 2010;85:701-710.
9. Finck BN. The PPAR regulatory system in cardiac physiology and disease. Cardiovasc Res 2007;73:269-277.
10. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 2001;98:5306-5311.
11. Abraham NG, Cao J, Sacerdoti D, Li X, Drummond G. Heme oxygenase: the key to renal function regulation. Am J Physiol Renal Physiol 2009;297:F1137-F1152.
12. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25: 1786-1795.
13. Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008;52:971-978.
14. Fan Y, Wang Y, Tang Z, Zhang H, Qin X, Zhu Y et al. Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 2008;28:315-321.
15. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001;7: 693-698.
16. Voghel G, Thorin-Trescases N, Farhat N, Mamarbachi AM, Villeneuve L, Fortier A et al. Chronic treatment with N-acetyl-cystein delays cellular senescence in endo-thelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 2008;129:261-270.